Novel imidazoline receptor homologs
OwnerJohn N. Feder, Gene G. Kinney +4inventors
InventorsJohn N. Feder, Gene G. Kinney, Gabriel Mintier, Chandra S. Ramanathan, David K. Bol, Rolf-Peter Ryseck
Life of this patent
Estimating the term…
Loading patent…
OwnerJohn N. Feder, Gene G. Kinney +4inventors
InventorsJohn N. Feder, Gene G. Kinney, Gabriel Mintier, Chandra S. Ramanathan, David K. Bol, Rolf-Peter Ryseck
Estimating the term…
Novel imidazoline receptor homologs, designated imidazoline receptor related protein 1 (IMRRP1), imidazoline receptor related protein 1b (IMRRP1b), and derivatives thereof are described. Pharmaceutical compositions comprising at least one IMRRP1, IMRRP1b, or a functional portion thereof, are provided as are methods for producing IMRRP1, IMRRP1b or a functional portion thereof. In addition, nucleic acid sequences encoding polypeptides, oligonucleotides, fragments, portions or antisense molecules thereof, and expression vectors and host cells comprising polynucleotides that encode IMRRP1 or IMRRP1b are provided. The novel association of IMRRP1 and/or IMRRP1b to modulating the NFkB pathway and the p21 cell cycle checkpoint, and uses thereof are also provided.
An isolated nucleic acid molecule consisting of a polynucleotide having a nucleotide sequence selected from the group consisting of:
The recombinant host cell of claim 6 comprising vector sequences.
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
An isolated antibody that binds specifically to the isolated polypeptide of claim 8.
A recombinant host cell that expresses the isolated polypeptide of claim 8.
A method of making an isolated polypeptide comprising:
A polypeptide produced by claim 11.
The method of diagnosing a pathological condition of claim 15 wherein the condition is a member of the group consisting of:
A method for treating, or ameliorating a medical condition with the polypeptide provided as SEQ ID NO:3, or a modulator thereof, wherein the medical condition is a member of the group consisting of:
A method of screening for candidate compounds capable of modulating the activity of a receptor polypeptide, comprising:
Dependencies are inferred from the claim text.